Related Experiment Video
Updated: Jan 19, 2026

Fertility Preservation in Patients with Severe Ovarian Dysfunction
Published on: March 25, 2021
Does sugammadex decrease the severity of agitation and complications in pediatric patients undergoing
Muge O Korkmaz1, Havva Sayhan, Mehmet Guven
1Otolaryngology Department, Sakarya University, Sakarya, Turkey. E-mail. ozcelikmuge@gmail.com.
Insights
Sugammadex significantly reduces recovery time and postoperative agitation in children after adenotonsillectomy compared to neostigmine plus atropine. This suggests sugammadex is a more effective reversal agent for neuromuscular blockade in pediatric patients.
Area of Science:
- Anesthesiology
- Pediatric Surgery
- Pharmacology
Background:
- Adenotonsillectomy is a common pediatric surgical procedure.
- Postoperative agitation, respiratory complications, and nausea/vomiting are significant concerns in pediatric recovery.
- Neuromuscular blocking agents are frequently used during general anesthesia, requiring effective reversal agents.
Purpose of the Study:
- To compare the efficacy of sugammadex versus neostigmine plus atropine in managing postoperative outcomes in children undergoing adenotonsillectomy.
- To evaluate the impact of sugammadex on extubation time, agitation, respiratory complications, and nausea/vomiting.
- To determine the optimal reversal strategy for neuromuscular blockade in this pediatric population.
Main Methods:
- A randomized controlled trial involving 70 pediatric patients (5-13 years) undergoing adenotonsillectomy.
- Patients were allocated to either the sugammadex group (Group S) or the neostigmine + atropine group (Group N), with 35 patients in each.
- Key metrics recorded included time to extubation, postoperative agitation scores, and incidence of early postoperative complications.
Main Results:
- Sugammadex group (Group S) demonstrated a significantly shorter time to extubation compared to the neostigmine + atropine group (Group N).
- Postoperative agitation scores were significantly lower in the sugammadex group.
- Fewer instances of coughing, nausea, and vomiting were observed in the sugammadex group, indicating a statistically significant reduction in complications.
Conclusions:
- Sugammadex is more effective than neostigmine plus atropine in reversing neuromuscular blockade after pediatric adenotonsillectomy.
- The use of sugammadex leads to faster recovery and reduced agitation and emetic symptoms in children.
- Sugammadex represents a favorable alternative for neuromuscular blockade reversal in pediatric surgical settings.
Objectives:
To evaluate the effectiveness of sugammadex in reducing or eliminating postoperative agitation levels, early respiratory complications and nausea/vomiting in children undergoing adenotonsillectomy.
Methods:
A total of 70 patients (age range: 5-13 years) who underwent an adenotonsillectomy in the Otolaryngology Clinic, Sakarya University, Sakarya, Turkey between May 2015 and September 2017 were included in the study. The patients were randomized into a sugammadex group (Group S) and a neostigmine + atropine (Group N); each group contained 35 patients. Time to extubation, postoperative agitation levels, and early postoperative complications were evaluated and recorded. Data from both groups were statistically evaluated and compared.
Results:
The time to extubation was significantly shorter in Group S than Group N (p less than 0.05). Agitation scores during recovery were significantly lower in Group S than Group N (p less than 0.05). More complications were observed in Group N than in Group S; the number of patients seen coughing and experiencing nausea/vomiting in Group S was statistically significantly lower (p less than 0.05).
Conclusion:
This study demonstrated that the use of sugammadex results in less time to recovery and less agitation in comparison to conventional administration of neostigmine + atropine in the reversal of neuromuscular blocking after adenotonsillectomy.
Related Concept Videos
12:03Fertility Preservation in Patients with Severe Ovarian Dysfunction
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
10:02Whole-body PET/MRI of Pediatric Patients: The Details That Matter
06:05Enema of Traditional Chinese Medicine for Patients with Severe Acute Pancreatitis

